GALVANI BIOELECTRONICS Trademark

Trademark Overview


On Monday, February 27, 2017, a trademark application was filed for GALVANI BIOELECTRONICS with the United States Patent and Trademark Office. The USPTO has given the GALVANI BIOELECTRONICS trademark a serial number of 87350882. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 15, 2024. This trademark is owned by Glaxo Group Limited. The GALVANI BIOELECTRONICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
galvani bioelectronics

General Information


Serial Number87350882
Word MarkGALVANI BIOELECTRONICS
Filing DateMonday, February 27, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 15, 2024
Registration Number5276484
Registration DateTuesday, August 29, 2017
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements


Description of MarkThe mark consists of the wording "GALVANI BIOELECTRONICS" in stylized form, the word "BIOELECTRONICS" appears in smaller capital block letters below "GALVANI" and between the middle of the first letter "A" and "I" in "GALVANI".
Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOELECTRONICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGALVANI BIOELECTRONICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type05 - Joint Venture
AddressBRENTFORD, MIDDLESEX TW89GS
GB

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, March 15, 2024CANCELLED SEC. 8 (6-YR)
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 29, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 15, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 29, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 5, 2017EXAMINER'S AMENDMENT ENTERED
Friday, May 5, 2017ASSIGNED TO LIE
Friday, May 5, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 5, 2017EXAMINERS AMENDMENT E-MAILED
Friday, May 5, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, May 4, 2017ASSIGNED TO EXAMINER
Monday, March 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 2, 2017NEW APPLICATION ENTERED